TALPHERA, INC. Deferred Revenue (Non-Current)
TALPHERA, INC. (TLPH) had Deferred Revenue (Non-Current) of $3.10 million as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2021-03-15
- 2020-03-31: Deferred Revenue, Noncurrent $3.10M.
- 2019-12-31: Deferred Revenue, Noncurrent $3.10M.
- 2018-12-31: Deferred Revenue, Noncurrent $3.15M.
- 2018-09-30: Deferred Revenue, Noncurrent $3.23M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2020-03-31 | $3.10M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.10M 10-K · filed 2021-03-15 |
| 2018-12-31 | $3.15M 10-K · filed 2019-03-07 |
| 2018-09-30 | $3.23M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $3.31M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $3.38M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.46M 10-K · filed 2019-03-07 |
| 2017-09-30 | $3.55M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $3.64M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $3.73M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $3.82M 10-K · filed 2018-03-09 |
| 2016-09-30 | $3.92M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $3.11M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $2.44M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $593.00K 10-K · filed 2017-03-03 |
| 2015-09-30 | $193.00K 10-Q · filed 2015-11-03 |
| 2015-06-30 | $1.59M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $1.63M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $1.63M 10-K · filed 2016-03-07 |
| 2014-09-30 | $1.69M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.69M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $2.01M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $2.01M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |